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Abstract
Lasers have wide applications in the treatment and diagnosis of diseases and various medical 
fields. Laser therapy like the other methods has advantages and disadvantages. Some risks such 
as bleeding, pain, and infection are created after laser therapy. Explanation and evaluation of 
laser effects on cell function, tissue, and the body are the aims of this study. We reviewed papers 
available from 1986 to 2019 about the effects of lasers on cells and tissue. An online search 
of PubMed, Science Direct and Google scholar using such keywords as “laser”, “cell”, “tissue”, 
“body” and “side effects” was performed. The laser photons are absorbed by chromophores, 
resulting in the target heating and localized damage. Laser irradiation alters cellular metabolism 
and cellular functions. These alterations may be accompanied by undesired side effects which 
can be monitored via metabolites level change in the body. Based on this finding, laser therapy 
may be associated with several side effects and complications; therefore, before treatment, the 
determination of laser types and their properties is necessary to avoid creating side effects. The 
advantages and disadvantages of the treatment type should be considered in order to choose the 
best treatment with the least side effects. The patients’ awareness of possible side effects before 
treatment and also an effective follow-up and management of patients after action are two 
important points in laser therapy. Training curriculum definition should be determined for laser 
applicant qualifications in different medical fields.
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Introduction
The first line of treatment in the case of many diseases 
is usually medication; however, the elevation of the 
therapeutic dose of drugs in numerous cases can lead to 
increasing further side effects. Patients are not satisfied with 
medical treatment due to incomplete pain control or drug 
side effects. Drowsiness, dizziness, fatigue, nystagmus, 
nausea, and memory loss are common side effects of drugs 
that require alternative treatment. When drug therapy is 
not useful and fails, other types of management such as 
surgical treatment and laser therapy1 are suggested. Laser 
therapy is commonly used in the treatment of diseases 
such as trigeminal neuralgia and dermatologic diseases.2 
Lasers, as the source of light or radiation energy, were 
described by Theodore Meimann in 1960.3 Laser devices 
produce electromagnetic radiation that is relatively 
uniform in wavelength, phase, and polarization. Different 
kinds of lasers are used for medical treatments. Laser 
therapy is a form of medicine that applies laser radiation 
to the surface of the body. While lasers are used to cut 
or remove tissue, relieve pain, reduce inflammation and 
edema, promote wounds, prevent tissue damage, and heal 
deeper tissues and nerves in medicine, they stimulate 
and enhance cell and tissue function. The effects of lasers 
are confined to the special set of wavelengths. Several 
studies indicate that laser therapy may be effective in 
relieving pain for nervous system diseases4,5 such as 
trigeminal neuralgia,6 rheumatoid arthritis,7 chronic 
neck pain,8 and osteoarthritis.9 Photons are absorbed 
by the electron absorption bands of the receptors called 
chromophores and cause the effects. The main tissue 
chromophores including hemoglobin and melanin have 
high absorption bands during shorter waves. Also, water 
strongly absorbs infrared photons at wavelengths above 
1100 nm. Therefore, using low-level lasers in medicine is 
known as a suitable tool. Low-Level Lasers such as ruby, 
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Argone, HeNe, and Krypton are types of lasers that affect 
biological systems through non-thermal means.10 In order 
to influence the visible light exposure to a living biological 
system, it can absorb photons by using electron capture 
bands belonging to some molecular photo-receptors. 
When the tissue chromophores, often hemoglobin, water 
or melanin, are affected by laser energy, the photon is 
absorbed, so it causes the target material to heat up and 
inflicts localized damage. In addition, laser energy is 
absorbed more rapidly and intensively through the skin 
and then causes localized damage.11 Furthermore, the 
person who directs the laser must be fully trained and 
skilled because lasers of an unspecified purpose can 
burn or destroy healthy tissue. Treatment complications 
of laser therapy may occur following the application of 
different types of laser devices and must be anticipated. 
In this article, we explain and evaluate several effects of 
lasers on cell functions, tissue, and the body.
Methods
Papers which explain the effects of lasers on cells, tissue 
and organisms and also laser therapy complication in the 
online journals that were published from 1986 to 2019 
were searched. An online search of PubMed, Science 
Direct and Google scholar using such keywords as “laser”, 
“cell”, “tissue”, “body” and “side effects” was performed. 
All documents in the English language were considered. 
The titles were screened and the suitable abstracts were 
studied. Finally, the appropriate articles were selected and 
the full text of these documents was extracted.
Introducing Laser Devices and Tissue Chromophores
Various types of laser devices are used in medicine. Table 1 
demonstrates a list of laser types, their applications, and 
their properties.3, 12-14 The fields in which relevant lasers are 
applied are also shown in Table 1. Tissue chromophores 
that absorb laser photons and the related absorbed 
wavelengths are tabulated in Table 2.15,16 Nucleic acid, 
protein, hemoglobin, melanin, water, lipid, elavins, and 
cytochrome oxidase are highlighted as chromophores.
Epidermal Side Effects of Laser Therapy
Laser therapy has been used for forty years to reduce 
pain, swelling, and inflammation, prevent tissue damage, 
heal wounds, and treat deeper tissues and nerves. In 
these fields, the laser stimulates or inhibits cell and tissue 
function which leads to clinical effects finally.17-20 
Before laser therapy, patients’ history including 
abnormal scarring, allergy, excessive sun exposure, 
herpes virus infection, any vascular and immunological 
disorders, tissue reinforced with silicone, smoking, and 
former cosmetic surgery must be considered. Because 
many drugs including amiodarone, minocycline, 
warfarin, isotretinoin, aspirin, niacin, vitamin E cause 
delayed healing, bleeding, scarring, increased bruising, 
hyperpigmentation, and localized chrysiasis after laser 
therapy, the medications that the patients have taken must 
be considered.21-23
The open wounds that are created after laser resurfacing 
and laser tattoo removal require daily care to optimize 
healing. Otherwise, infection, persistent erythema, and 
scarring are created. There are a variety of complications 
after reconstructive surgery and facial rejuvenation using 
CO2 and Er: YAG lasers. These include bacterial and viral 
infections, pain, persistent erythema, delayed healing, 
scarring, hypopigmentation, hyperpigmentation, acne, 
Table 1. The List of Various Lasers Which Are Used in the Treatment of Different Types of Diseases and the Application Cases and Their Properties
Laser Type Wavelength (nm) Chromophore Application
Ruby 694 Pigment, hemoglobin Dermatology
Nd:YAG 1064 Pigment, proteins, hemoglobin Wide application
Ho:YAG 2130 Water Surgery, root canal lithotripsy
Er:YAG 2940 Water Surgery, dental drill
KTP 532 Pigment, hemoglobin Dermatology
Alexandrite 720-800 Pigment Bone cutting
HeNe 633 Pigment, hemoglobin Photodynamic therapy
Argone 350-514 Pigment, hemoglobin Surgery, photodynamic therapy, dermatology
Diod lasers 630–98 0nm Pigment, water, proteins Photodynamic therapy surgery
Co2 10600 Water Surgery
ArF Excimer 193 Proteins Corneal surgery
XeCl Exicimer 308 Proteins, lipids Dermatology
Nitrogen 337 Pigment Dermatology
Copper Vapor 578 Pigment Dermatology
Gold Vapor 628 Pigment Photodynamic therapy
Argon-pumped dye 630-690 Pigment Photodynamic therapy
KTP pumped dye 630-635 Pigment Photodynamic therapy
Flash lamp pumped dye 580-600 Pigment Dermatology
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milia, ectropion, pruritus, contact dermatitis, vascular 
proliferation, and eruptive keratoacanthomas.24-28 
Now many new pulsed dye laser generations are 
available with variable pulse duration, longer wavelengths, 
faster repetition rates, larger spot sizes, and epidermal 
cooling devices. Although these upgraded devices 
improve clinical results, some complications and side 
effects have not been eliminated completely. For example, 
several complications of pulsed dye laser therapy such 
as purpura, blisters, pain, crusting, hypopigmentation, 
hyperpigmentation, dermatitis, and atrophic scarring 
have remained.29,30 However, researchers have identified 
that laser therapy is associated with a relatively low 
complication rate. The complications and side effects 
that are observed after laser treatment are temporary and 
are not dramatically severe or do not lead to long-term 
effects.31
Effects of Laser on Cell Function
In cells, mitochondria are the first site to show the early 
effects of laser with photon absorption. After photon 
absorption by the cytochrome c oxidase enzyme, the 
chromophore for the red-NIR range, an electron-excited 
state, and an intensified electron transfer reaction are up-
regulated. This process leads to the increment of ATP 
production, the modulation of reactive oxygen species, 
and the induction of expression of TNF transcription 
factors.32 Changes in cellular redox status regulate many 
transcription factors  such as NF-κB, Ref-1, p53, ATF/
CREB, and HIF-1α. This then induces transcriptional 
changes and the activation of several intracellular 
signaling pathways such as protein synthesis, nucleic acid 
synthesis, cell cycle progression, and enzyme activation. 
Additionally, it stimulates the differentiation of some 
cell types33 and leads to increased cell proliferation 
and cell migration, growth factors and inflammatory 
mediators, and the modulation of cytokines (Figure 1).34 
All mentioned alterations are accompanied by possible 
dysregulation in the molecular mechanism of cell function 
because cell proliferation and cell cycle progression are 
important processes on which cell function depends.35 
Also, lasers alter cellular metabolism and transcription 
factors which are responsible for gene expression.36
Metabolomic Effect of Laser
Intravascular laser blood irradiation is used in the 
treatment of various diseases. Laser irradiation therapy 
influences the whole of organisms, cells, and tissues 
and it may alter the metabolome profile. It induces ATP 
synthesis and energy formation in cells, reduces the status 
of glucose, cholesterol, low-density lipoproteins, and very 
low-density lipoproteins, stabilizes the hormonal and 
immune system, and increases arginine and nitric oxide 
production. Arginine causes the release of some hormones 
such as glucagon, insulin, growth hormone, adrenalin, 
prolactin, and catecholamines.37-39 In diabetic patients, 
after laser blood irradiation, levels of main metabolites 
such as glucose, glucose-6-phosphate, dehydroascorbic 
acid, R-3-hydroxybutyric acid, L-histidine, and L-alanine 
decrease and L-arginine increase in plasma.40
Table 2. Various Types of Tissue Chromophores and Their Main Absorption 
Wavelengths
Chromophores Absorption Wavelengths (nm)
Nucleic acid 260-280
Protein 280-300














































Figure 1. A Schematic View of Laser Effects on Cellular Function. Processes start with photon absorption and end to the related biological effects.
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Hypertrichosis After Laser Therapy
In 1996 after the approval of FDA, because of the 
relative safety and efficacy of lasers and highly pulsating 
lasers (HPLs) treatments, HPLs were commonly used 
to terminate unwanted hair growth by using laser 
wavelengths in the red and 600-1100 nm range and pulsing 
light energy to melanin in hair shafts. Upon absorption, 
the light converts to thermal energy and destroys the hair 
follicle precursor cells while destroying the surrounding 
tissue.41,42 After a few months, Hypertrichosis, a rare 
and significant side effect, occurs in areas treated with 
laser devices with low fluencies and all laser types43 
such as Nd:YAG, diode lasers, and alexandrite lasers.44-48 
Hypertrichosis is the result of suboptimal rays that 
are too low to stimulate thermolysis and high enough 
to induce follicular growth and convert follicles from 
telogen (resting phase) to anagen (active phase) or 
transform vascular follicles into terminal follicles. It 
mostly occurs in the patients’ face and neck with darker 
skin and coarse hair with hormonal imbalances.10,13 Its 
pathogenesis includes the regulation of prostaglandin 
E2 (inflammatory mediator) production by ultraviolet 
radiation and stimulation. Reversible hypertrichosis and 
hair growth occur when it is applied topically.49,50 
Diabetic Retinopathy and Laser Therapy
Diabetic retinopathy laser therapy is an effective 
treatment to prevent vision loss in diabetic patients. Laser 
therapy is an effective method for preventing vision loss 
and maintaining long-term vision, but it is inherently 
destructive and is associated with side-effects, especially 
with regards to dark adaptation, peripheral visual 
function, and night vision.14,51
Laser photon is absorbed by pigment cells in the retina, 
thereby increasing the temperature in the cell and heating 
it and thus destroying the outer retina cells including 
the outer receptor photon and the retinal pigment 
epithelium. Therefore, the laser burns and leads retinal 
to thinning and results in an increased retinal ability to 
extract oxygen from the choroid. Thinning of the retina 
improves relative oxygenation in the retinal tissue, but 
it is ischemic destruction and retina also decreases the 
release of angiogenic growth factors such as VEGF. This 
process leads to regression or disappearance of retinal 
vascular vessels.52-55
Pain, development of macular edema, losing visual 
field, reduction in night vision, color vision loss, retinal 
scarring, and reduction in contrast sensitivity are seen 
in several diabetic patients after retinopathy laser 
therapy.56-58 However, most patients are able to tolerate 
pain, but shortening the duration of the laser pulse, 
specifically avoiding prolonged posterior nerves in three 
to nine hours’ position and failing treatment in a few 
sessions can reduce pain and improve patients’ condition. 
Using longer laser wavelengths is more uncomfortable 
and limits the ability to tolerate pain in some patients.59-61 
Although macular edema is resolved within weeks to 
months after laser therapy in some patients, it can lead 
to their loss of visual acuity. To reduce macular edema 
after laser therapy, the number of laser spots delivered per 
session must decrease.62-64
The negative effect of lasers on peripheral visual fields 
has been studied by evaluating the visual correctness 
of different laser techniques. Scores for the visual field 
in diabetic patients after laser therapy on the four-year 
visit are worse and the visual field reduces. Moreover, 
diminished color vision after laser therapy is reported.65,66 
Decreased night vision and contrast sensitivity have 
also been reported following laser therapy in several 
studies.67 Choroidal detachment or effusions, commonly 
and potentially adverse effects of laser therapy, lead 
to the anterior angle shallowing, elevated intraocular 
pressure or angle closure glaucoma and are resolved 
with any treatment and rarely cause visual sequelae.68 
Vascular congestion of the choroid almost happens after 
xenon or argon laser therapy and causes the eyelashes to 
rotate to the shallow anterior chamber and transiently 
increases intraocular pressure. This can lead to transient 
accommodation and transient myopia or transient 
increased intraocular pressure.69
Laser therapy can result in misdirected or excessively 
intense burns, bleeding from the choriocapillaris, 
damage to macular and other ocular structures, and 
breaks in Bruch’s membrane. The use of excessive energy 
in laser therapy breaks Burch’s membrane and then 
fibroblast growth factor synthesis and the retinal pigment 
epithelium active to synthesize vascular endothelial 
growth factor that leads to the development of choroidal 
neovascularization.70-72
In several patients after the laser procedure, many side 
effects including choroidal detachment, hollowing of 
the anterior chamber, exudative retinal detachment, and 
increased intraocular pressure are reported.73,74
After laser therapy, we need to follow up patients and 
checkup some factors such as change and appearance 
in vessels, vitreous hemorrhage frequency and extent, 
vitreous detachment status, scars extent, and fibrous 
proliferations extent from the last retinopathy laser 
therapy on.75
Conclusion
Laser therapy requires highly trained and skilled people 
who have to carry out the laser procedure and give 
precautions after surgery to the patient, and caring after 
the laser operation is very important to get the desired 
result. Some after-effects of treatment, such as scarring 
and hypopigmentation may appear several months after 
laser application. Laser therapy is not a method without 
side effects and most of the times it is accompanied by 
failures. The probability of adverse side effects should 
be meticulously compared to beneficial results to make 
a reasonable clinical decision from one patient to the 
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other. Patient satisfaction is an important point and many 
side effects cannot be avoided; therefore, all possible risks 
and potential complications after laser therapy should 
be explained to patients. Patients should be aware of 
long-term risks before laser therapy. If an undesirable 
complication is managed immediately, the prevention of 
permanent damage may be possible. 
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